Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Bahiafarma

Tracked across 1 events · 6 articles · First seen Sep 08, 2026 · Last active Sep 08, 2026

Sentiment
30
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 30
Business
Biocon, an Indian biopharmaceutical company, signed a partnership agreement with Bahiafarma, a public pharmaceutical laboratory of the State of Bahia, and Bionovis, a Brazilian biotechnology company, to manufacture and commercialize Pertuzumab, a monoclonal antibody for…
Impact: Bahiafarma, as a public laboratory, gains technology transfer and local production capabilities, aligning with its mission to supply medicines to Brazil's public health system.
Sep 08, 2026 · 6 articles
100 Biocon signed partnership agreement BahiafarmaBiocon Brazil Pertuzumab PDP Deal
ERGEN INTELLIGENCE
Track Bahiafarma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.